Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Nat Prod Res ; 36(8): 1927-1933, 2022 Apr.
Article in English | MEDLINE | ID: mdl-33107346

ABSTRACT

A new diarylheptanoid, (1 R,2S,3S,5S)-2,3-dihydroxy-3',3''-dimethoxy-4'-de-O-methylcentrolobine (1) and a new bisabolane-type sesquiterpenoid, (1 R,7S)-1,12,13-trihydroxybisabola-3,10-diene (2), together with nineteen known compounds (3-21) were isolated from the EtOH extract of the stems and branches of Viscum coloratum (Kom.) Nakai. Their structures were elucidated by extensive analysis of 1 D and 2 D NMR spectra and from the HRESIMS. All the compounds were evaluated for their cytotoxic activity against eight human tumor cell lines.


Subject(s)
Antineoplastic Agents , Viscum , Diarylheptanoids , Humans , Magnetic Resonance Spectroscopy , Viscum/chemistry
2.
Zhonghua Yan Ke Za Zhi ; 47(8): 726-31, 2011 Aug.
Article in Chinese | MEDLINE | ID: mdl-22169613

ABSTRACT

OBJECTIVE: To investigate the differential expression of complement C4b and transthyretin in proliferative vitreoretinopathy (PVR). METHODS: It was a controlled experimental study. Human vitreous samples of 5 patients with PVR were analyzed by using two-dimensional gel electrophoresis and mass spectrometry, and the results were compared with those from normal control vitreous obtained from donor eyes. An in vivo model of PVR was created by intravitreous injection of cultured rabbit retinal pigment epithelial (RPE) cells. The vitreous of PVR models were analyzed by enzyme linked immunosorbent assay (ELISA) to confirm the proteomic results from the PVR patients. RESULTS: Seventy nine various proteins were expressed differently between PVR and normal vitreous, among which nine up-regulated proteins including complement C4b, transthyretin (TTR), and 7 albumins were identified by mass spectrometry. The up-regulation of complement C4b and TTR in PVR patients was also confirmed by ELISA. The concentration of complement C4b and TTR in normal vitreous were (20.18 ± 1.97) mg/L and (88.58 ± 8.84) mg/L respectively, in PVR patients were (38.1 ± 5.79) mg/L and (112.57 ± 6.89) mg/L respectively, difference significantly between these two groups (C4b: t = 11.54, TTR:t = 9.24; P < 0.05). CONCLUSIONS: Differences of complement C4b and TTR expression were observed between PVR and normal vitreous. These results have lead to the assumption that there is a connection between elevated concentrations of both complement C4b and TTR and the pathogenesis of PVR and further studies on the functions of these proteins are required.


Subject(s)
Complement C4b/metabolism , Prealbumin/metabolism , Vitreoretinopathy, Proliferative/metabolism , Adult , Animals , Case-Control Studies , Electrophoresis, Gel, Two-Dimensional , Female , Humans , Male , Middle Aged , Proteomics , Rabbits , Vitreoretinopathy, Proliferative/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...